Rhumbline Advisers Boosts Holdings in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
24 minutes ago • Google News
Crinetics Pharmaceuticals Inc (CRNX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 3.2B
P/E Ratio
0.00
Revenue (TTM)
$ 1.39M
Volume
0
52W High
$ 62.53
52W Low
$ 24.10
Dividend Yield
0.00%
Beta
0.28
Technicals
50-Day MA
30.9058
200-Day MA
35.9862
52 Week High
62.53
52 Week Low
24.1
About CRNX
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-r.
Employees
437
Headquarters
San Diego, CA
CEO
Dr. R. Scott Struthers Ph.D.